OBJECTIVE: This study examined the effect of endoscopic sinus surgery (ESS) on plasma levels of asymmetric dimethylarginine (ADMA) and mean pulmonary arterial pressure (mPAP) in patients with extensive nasal polyposis (ENP). METHODS: Preoperative and 3month post-ESS plasma levels of ADMA and mPAP were measured in patients with ENP and in age-and gender-matched controls. RESULTS: The study included 45 patients with ENP and 31 controls (mean ± SD age 39.4 ± 8.8 and 38.1 ± 9.6 years, respectively). The mean preoperative ADMA level in ENP patients (0.69 ± 0.27 µmol/l) was statistically significantly lower than in the control group (1.08 ± 0.37 µmol/l). The postoperative ADMA level increased significantly in ENP patients (0.97 ± 0.36 µmol/l) versus the preoperative level. Mean preoperative mPAP in ENP patients (25.7 ± 5.4 mmHg) was statistically significantly higher than in the control group (20.8 ± 2.1 mmHg), and ENP patients showed significant decreases in mPAP after (21.9 ± 3.5 mmHg) versus before ESS. CONCLUSION: Patients with ENP had lower plasma ADMA levels compared with healthy controls, however ADMA levels and mPAP improved in ENP patients after ESS.
Introduction
Extensive nasal polyposis (ENP) is a medical condition affecting about 2 -4% of the population, and is characterized by chronic inflammation of the nasal cavity and paranasal sinuses mucosal membranes. 1 ENP increases upper airway obstruction, pulmonary arterial pressure (PAP), 2 and cor pulmonale, which is cited as the cause of death of patients with airway obstruction. 3, 4 Prolonged elevation of PAP may reduce cardiac function, leading to increased cardiovascular risk in patients with ENP. 5 The pathophysiology of this effect has not, however, been fully studied.
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only as an atmospheric pollutant, is now known to be an important mediator in a variety of physiological processes (for example, it is a potent vasodilator) and performs major functions in host defence systems. NO is produced by the epithelium of the paranasal sinuses where it plays a role in the development of inflammation, secretion and obstruction leading to nasal polyposis. 6 L-Arginine, a semi-essential basic amino acid is involved in many physiological processes, including the synthesis of NO which is catalysed by NO synthase and is disrupted by methylated L-arginine analogues such as asymmetric dimethylarginine (ADMA). 7 ADMA is a competitive inhibitor of NO synthase; therefore, NO levels decrease with increased ADMA levels, 8 leading to endothelial dysfunction. Investigators have also suggested that decreased NO can lead to pulmonary arterial hypertension and other cardiovascular diseases. 9 -12 Furthermore, ADMA has been shown to be a potential independent marker of cardiovascular risk. 13 -15 Controversies persist with respect to the management of ENP. Medical management is preferred but endoscopic sinus surgery (ESS) is indicated for ENP in patients who fail to respond to corticosteroid therapy. 16 To the best of our knowledge, no previous study has investigated the association between ENP and ADMA levels before and after ESS. Thus, the aims of the present study were to determine the levels of ADMA and PAP in patients with ENP, to assess the impact of ESS on these measurements, and to compare the findings with a control group.
Patients and methods

STUDY POPULATION
Consecutive patients who presented with ENP at the Otolaryngology Clinic of the Ear, Nose and Throat Department, Erzurum Education and Research Hospital, Erzurum, Turkey, between March 2007 and February 2010 were recruited to the study. Age-and gender-matched controls were recruited from among healthy patients attending the same hospital during the same study period.
At study entry, routine blood and urine analyses and cardiopulmonary graphs and chest X-rays were conducted in all subjects. Patients and controls both underwent endoscopic nasal examination, and paranasal sinus computed tomography (CT) was conducted for the diagnosis of nasal polyposis. ENP patients who were unresponsive to corticosteroid therapy were included in the study and undwerwent ESS. Patients and controls who had previously been diagnosed with any cardiovascular disease, and patients who had received prior ESS were excluded. ENP patients and controls with any clinical or laboratory evidence of inflammation or infection, or who had received hormone therapy and/or steroid therapy in the 2 months prior to the study, or were taking any drugs that might affect ADMA levels (including angiotensinconverting enzyme inhibitors, angiotensinreceptor antagonists, or aspirin) were also excluded from the study.
Written informed consent was obtained from all patients. This study was approved by the Ethical Committee of Erzurum Education and Research Hospital, Erzurum, Turkey.
CARDIAC MEASUREMENTS
Pulmonary arterial pressure was measured using coloured Doppler echocardiography (GE Vivid™ S5; GE Healthcare, Wauwatosa, WI, USA), and was performed in all ENP and control patients preoperatively and in the ENP patients 3 months postoperatively. All of the procedures were carried out using automated processes by an independent V Fidan, H Alp, F Karaca et al.
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analyst. Mean PAP (mPAP) for each patient was calculated from four individual measurements; 25 mmHg was considered the maximum threshold for mPAP. Any value above this level was considered pulmonary hypertension and values of 12 -20 mmHg were considered to be normal (21 -25 mmHg was regarded as neither normal nor pathological). Patients with PAP > 25 mmHg were not excluded from the analysis.
BLOOD SAMPLING AND IMMUNOASSAY
Blood samples for the measurement of ADMA were collected in BD Vacutainer ® CPT™ tubes containing sodium heparin (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) preoperatively for all ENP patients and controls, and at 3 months postoperatively in the ENP patients. Blood samples were centrifuged for 10 min at 2000 g and stored at -70°C until analysis. The ADMA levels were analysed using an ADMA direct enzyme-linked immunosorbent assay (ELISA) kit (Immundiagnostik AG, Bensheim, Germany) (standards 0.1 -2.0 µmol/l). Three measurements were taken to calculate the mean ADMA levels. The cut-off point for normal ADMA blood concentration was ≤ 0.80 µmol/l.
ANAESTHESIA AND SURGERY
All ENP patients who were resistant to medical therapy were eligible for ESS, which was carried out by the same surgeon (V.F.) under local anaesthesia and sedation using the same protocol: 2 mg/kg parenteral lidocaine by submucosal injection into the nasal mucosa for local anaesthesia and 0.1 mg/kg midazolam orally for sedation. A full 10 min was allowed for the local anaesthesia to take effect. The CT scans for each patient were reinspected and ESS was carried out using the Messerklinger technique as described previously. 17 After completion of surgery, haemostasis was checked and nasal packing was applied.
During the postoperative period all patients remained in the hospital for observation for 24 h. The nasal packing was removed 24 h after surgery. Postoperative complications were monitored in the ENP patient group for 2 weeks by a single investigator (V.F.) by rigid endoscopy.
STATISTICAL ANALYSES
Statistical analyses were carried out using the SPSS ® software package, version 17.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Categorical variables are presented as percentages and continuous variables are presented as mean ± SD. The ENP patient and control groups were compared using a paired samples t-test for normally distributed variables and the Wilcoxon signed-rank test for non-normally distributed variables. McNemar's test was used to test for statistical differences between preoperative and postoperative ADMA values. A value of P < 0.05 was considered to be statistically significant.
Results
In total, 45 patients with ENP were enrolled into the study (mean ± SD age 39.4 ± 8.8 years; 28 The mean preoperative ADMA level of the ENP group was statistically significantly lower than that of the control group (P < 0.001). A significant increase in ADMA levels occurred 3 months after operation in the ENP group (P < 0.001; Table 1 ). 
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Preoperatively, 37 (82.2%) ENP patients and only three (9.7%) control patients had a mean ADMA level ≤ 0.80 µmol/l whereas, at 3 months postoperation, 10 (22.2%) ENP patients still had a mean ADMA level ≤ 0.80 µmol/l; hence, in 27 (60.0%) ENP patients, the mean postoperative ADMA level was normalized compared with preoperative levels (P < 0.001, McNemar's test).
The preoperative mPAP of the study patients was statistically significantly higher than that of the control group (P < 0.001; Table  2 ). A statistically significant decrease occurred in 3-month postoperative versus preoperative mPAP in the ENP patients (P < 0.001; Table 2 ). Preoperatively, 32 (71.1%) ENP patients and 28 (90.3%) control patients had a mean mPAP in the normal range (12 -20 mmHg) whereas, at 3 months postoperation, four (8.9%) ENP patients still had a mean mPAP above normal; hence, in nine (20.0%) ENP patients, mean postoperative mPAP level was normalized compared with preoperative levels (P < 0.001, McNemar's test).
Postoperative complications occurred in four study patients (8.9%): synechia was noted in two patients (4.4%) and postoperative epistaxis occurred in two patients (4.4%). The two patients with synechia received additional surgery to resolve it and a nasal tampon was reapplied in the two patients who experienced postoperative epistaxis.
Discussion
The present study demonstrated that patients with ENP had significantly decreased ADMA levels compared with 
TABLE 1: Comparison of preoperative and 3-month postoperative mean plasma asymmetric dimethylarginine (ADMA) levels in patients with ENP and compared with the level in control patients
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controls and that, following ESS, ADMA levels increased to levels similar to those of the control group. The possible mechanisms for these findings are still unclear; however, the endothelium, NO and ADMA levels may all be implicated. The endothelium of vascular tissue has many functions with regard to the maintenance of normal vascular homeostasis and it controls vasodilation via the endothelial-derived relaxing factor, NO. 18 Increased NO activity results in vasodilation, 19 -21 whereas endothelial dysfunction may decrease NO release. Endogenous ADMA is an inhibitor of NO synthase activity. 22 ADMA has appeared as a significant cardiovascular risk marker in many studies. A positive relationship also exists between ADMA levels and age > 60 years; 21 however, this is not relevant to the present study as none of the included patients was > 60 years of age. Several drugs, such as angiotensin-converting enzyme inhibitors, angiotensin-receptor antagonists and aspirin, have been reported to decrease plasma ADMA levels. 23 Patients' drug history was taken into consideration in the present study to avoid any drug effect on ADMA levels. Additionally, decreased ADMA levels are positively correlated with endotheliumdependent vasodilation. 24 ADMA may also affect vascular thickness, as well as vascular endothelial reactivity. 23 -27 Nasal polyps are characterized by stromal oedema and increased submucosal thickness. In cases with panpolyposis, the cardiovascular symptoms are usually mild. 27, 28 The preoperative mPAP of patients with ENP in the present study was significantly higher than that of the controls. Moreover, the mPAP of the ENP patients was significantly reduced after ESS, suggesting that patients with higher mPAP and with extensive nasal polyposis could be treated by ESS and could benefit from improvements to their cardiopulmonary system. The postoperative complications observed in the present study are unlikely to have affected the study outcomes. Two patients had an epistaxis and their outcomes were not different from those of other patients.
Preoperative plasma levels of ADMA in patients with ENP in the present study were significantly lower than in the control group. Moreover, the plasma ADMA level of the ENP group increased significantly after ESS. Elevated ADMA levels lead to vasoconstriction via NOS, although this is not the only parameter that causes vasoconstriction. 29 The present study showed that, despite low levels of ADMA in ENP patients, mPAP was raised in the preoperative period and, although an increased ADMA concentration was observed in ENP patients following ESS, mPAP was lowered during the postoperative period. This finding is in direct contrast to a study in patients with congenital heart disease and pulmonary hypertension. 30 ADMA is, however, only a single parameter that can affect the cardiovascular disease risk of ENP patients and it is difficult to establish the role of ADMA based on the present study, particularly due to the small sample size.
In patients with ENP, a timely determination for surgery and the planning of appropriate medical therapy may prevent the onset of potential cardiovascular-related pathology. Detailed investigations with larger sample sizes must, however, be performed to establish the pathophysiology of ADMA and other antioxidant parameters, and their effect on cardiovascular disease in patients with ENP during long-term follow-up.
